Objectives. Motor coordination problems are frequent in children with attention deficit/hyperactivity disorder (ADHD). We performed a genome-wide association study to identify genes contributing to motor coordination problems, hypothesizing that the presence of such problems in children with ADHD may identify a sample of reduced genetic heterogeneity. Methods. Children with ADHD from the International Multicentre ADHD Genetic (IMAGE) study were evaluated with the Parental Account of Children's Symptoms. Genetic association testing was performed in PLINK on 890 probands with genome-wide genotyping data. Bioinformatics enrichment-analysis was performed on highly ranked findings. Further characterization of the findings was conducted in 313 Dutch IMAGE children using the Developmental Coordination Disorder Questionnaire (DCD-Q). Results. Although none of the findings reached genome-wide significance, bioinformatics analysis of the top-ranked findings revealed enrichment of genes for motor neuropathy and amyotrophic lateral sclerosis. Genes involved in neurite outgrowth and muscle functions were also enriched. Among the highest ranked genes were MAP2K5, involved in restless legs syndrome, and CHD6, causing motor coordination problems in mice. Further characterization of these findings using DCD-Q subscales found nominal association for 15 SNPs. Conclusions. Our findings provide clues about the aetiology of motor coordination problems, but replication studies in independent samples are necessary.
Introduction
With a prevalence of 5% at school age, motor coordination problems are common in children and are usually referred to as developmental coordination disorder (DCD) (American Psychiatric Association 2000; Kirby and Sugden 2007; Missiuna et al. 2008; Lingam et al. 2009 ). DCD is a heterogeneous condition. Motor milestones such as crawling and walking may be delayed, while some children show hypotonia and/or clumsiness (Green et al. 2008; Wilson and Larkin 2008) . The motor problems lead to difficulties in everyday living and often have an effect on academic performance, sports, play and self-esteem (Cummins et al. 2005; Polatajko and Cantin 2005; Miyahara and Piek 2006; Piek et al. 2008) . Delay of brain maturation as well as functional deviations in basal ganglia, parietal lobe and cerebellum have been suggested as the dominant source of neuropathology in motor coordination problems (Zwicker et al. 2009) . DCD is considered a multifactorial disorder in which genetic factors and environmental factors such as perinatal adversity play a role (Pearsall-Jones et al. 2009 ). The one study formally examining the heritability of DCD in a population-based twin study (Martin et al. 2006 ) estimated it to be 0.69. In our study of sib pairs, we found a familial component (comprising genetic and environmental effects) of 0.47 (Fliers et al. 2009 ).
The genetic component appears polygenic, with many genes of small effect thought to causing the disorder in unfavourable environmental circumstances.
Children with motor coordination problems usually have problems in other areas of development as well, including dyslexia, autistic spectrum disorders and attention deficit/hyperactivity disorder (ADHD). The other way around, we and others have found that of children with ADHD, 30 -50% also suffer from motor coordination problems (Gillberg et al. 2004; Fliers et al. 2008) . The combination of ADHD and motor coordination problems has previously been named deficits of attention and motor perception, DAMP (Kadesjo and Gillberg 1998; Gillberg et al. 2004 ). At present, we can only speculate about the underlying neurobiological mechanisms for this comorbidity, but a dopamine-induced imbalance of basal ganglia neurocircuits may play a role (Arnsten 2006) .
Previous work on the familiality of these two disorders identified a possible shared etiological background. In the Dutch sample of the International Multicenter ADHD Genetics (IMAGE) study, we found that ADHD and motor coordination problems have a common basis that may be due to genetic factors and/or shared environmental factors. The familial correlation between motor performance measures and ADHD was found to be 0.38 (Fliers et al. 2009 ). These results are in line with a twin study of the shared background of ADHD and DCD, in which a shared heritability of between 29 and 51% was observed (Martin et al. 2006) .
Despite the considerable familial component involved in motor coordination problems (Fliers et al. 2009 ), little is known about the specific genetic factors involved. Since such knowledge may help to better understand the aetiology of motor coordination problems, we set out to perform a hypothesis generating genome-wide association study (GWAS) to search for DNA variation contributing to the condition. Genomewide association studies are a powerful tool to identify genetic factors of limited effect size (McCarthy et al. 2008) . In GWAS, hundreds of thousands of single nucleotide polymorphisms (SNPs) across the genome are tested independently for their association with a trait/disorder. This method has revolutionized the search for genetic influences on complex traits such as ADHD, in which both genetic and environmental factors work together (Franke et al. 2009 ). The SNPs analyzed in GWAS are selected to "tag" or capture the majority of genetic variation in their vicinity, which is possible because the human DNA is organized in blocks of genetic material that is transmitted together across generations. This means that if we genotype one given SNP, we will be able to flag or predict the variation of several other SNPs including those contributing to the trait/disease.
We hypothesized that studying motor coordination problems in a sample of ADHD-affected children might reduce the phenotypic and genetic heterogeneity of motor problems. In the current study, 890 children from the IMAGE study were included. We performed bioinformatics analysis on the highest ranked findings to test for enrichment of gene functional groups.
Findings were further characterized in more detail using a second phenotyping instrument in the Dutch IMAGE subsample.
Methods

Participants:
Children with ADHD and their siblings were recruited for the IMAGE study that aims at identifying genes that increase the risk for ADHD using QTL linkage and association strategies (Brookes et al. 2006; Kuntsi et al. 2006) . Families were identified through ADHD probands aged 5 -17 years attending outpatient clinics at the data collection sites in Europe (Belgium, Germany, Ireland, The Netherlands, Spain, Switzerland, and the United Kingdom) and Israel. Families of European Caucasian ancestry were recruited based on having one child with ICD-10 or DSM-IV ADHD and at least one other child who would provide DNA and quantitative trait data. In addition, both parents had to be available for DNAsampling. The ADHD diagnosis was based on DSM-IV criteria using both parent and teacher questionnaires and standardized interviewing. Diagnostic instruments used were the Parental Account of Childhood Symptoms (PACS) interview (see below), Conners' Parents and Teachers long versions, and the SDQ (Strengths and Difficulties Questionnaire).
Exclusion criteria included an IQ < 70, known genetic syndromes (Down, Turner, Fragile X), autism, seizures (current or in the past), brain disorders (such as periventricular haemorrhage, cerebral palsy and epilepsy), and disorders mimicking ADHD symptoms. When children were using medication to treat their ADHD symptoms, the parents were asked to report on their children's behaviour off medication. For additional details about the clinical characteristics and the diagnostic process, see Brookes et al. 2006; Kuntsi et al. 2006; Chen et al. 2008; Christiansen et al. 2008; Zhou et al. 2008; Mulligan et al. 2009 .
The following disorders co-occur with ADHD in the IMAGE sample: mood disorder (15%), anxiety disorder (44%), oppositional defiant disorder (64%) and conduct disorder (24%) (Muller et al. 2011) . Both the mean and median IQs were 98. Children with and without motor problems did not differ according to age, gender and also severity of ADHD symptoms (Fliers et al. 2008 ).
Motor measures: Parental Account of Children's Symptoms (PACS) interview.
The PACS, a semi-structured, standardized, investigator-based interview (Taylor et al. 1986) , was administered to all parents. To ensure cross-site consistency in measurement and coding, all interviewers attended a 5-day PACS training course in the UK. The sites' chief investigators additionally attended annual inter-rater reliability exercises. The mean kappa coefficient across all sites was high (0.88). The PACS also includes questions regarding motor development of which we analysed the question "does your child have motor coordination problems" , with three possible answers: "no" , "maybe", or "yes definitely" as the primary phenotype for genetic analysis.
Developmental Coordination Disorder Questionnaire (DCD-Q).
In the Dutch participants of IMAGE, we collected additional data on motor performance with the DCD-Q, completed by parents (Fliers et al. 2008) . The DCD-Q identifies children with motor coordination problems in daily life and is widely used in international studies (Wilson et al. 2000 (Wilson et al. , 2009 Loh et al. 2009 ) The Dutch DCD-Q has been validated (Schoemaker et al. 2006 ). The internal consistency of the questionnaire is high (α = 0.88). The DCD-Q contains 17 items that are rated on a five-point scale (1 = not at all like this child; 5 = extremely like this child) and 4 subscales: motor control in motion, fine motor control/handwriting, gross motor control/planning and general coordination. In this study DCD-Q scores (on a continuum) were tested as secondary phenotypes in the genetic analysis of candidate SNPs. We tested 5 traits: the total score on the DCD-Q (range from 17 to 85), and the 4 subscale scores.
Genetic analysis
The IMAGE consortium is a part of the Genetic Association Information Network (GAIN), a public private partnership of FNIH (Foundation for the National Institutes of Health, Inc.) (http:// www.fnih.org). A total of 958 affected proband -parent trios from IMAGE were initially selected for genome-wide genotyping conducted at Perlegen Sciences using their genotyping platform of approximately 600,000 tagging SNPs designed to be in high linkage disequilibrium with untyped SNPs for the HapMap populations. Quality control of the genotype data was performed by NCBI (The National Center for Biotechnology Information) using the GAIN QA/QC Software Package (version 0.7.4). Details of the genotyping and data cleaning process for the ADHD GAIN study (Study Accession, phs000016.v1.p1) have been reported elsewhere (Neale et al. 2008) . Briefly, we selected only SNPs with minor allele frequency (MAF) ≥ 5% and HardyWeinberg equilibrium (HWE) P ≥ 1.00E-06. Genotypes causing Mendelian inconsistencies were identified by PLINK (http://pngu.mgh.harvard.edu/purcell/pli nk/) and removed (Purcell et al. 2007 ).
We additionally removed SNPs that failed the quality control metrics for the other two GAIN Perlegen studies (major depression disorder (dbGAP Study Accession phs000020.v1.p1) and psoriasis (dbGAP Study Accession phs000019.v1. p1)). With this filtering, 384,401 autosomal SNPs were retained in the final dataset. To increase coverage of the genome, we used the imputation approach implemented in PLINK (v1.04), which imputes genotypes of SNPs that are not directly genotyped in the dataset, but that are present on a reference panel. The reference panel used consisted of 2,543,285 polymorphic autosomal SNPs genotyped on the 60 HapMap Caucasian (CEU) founders which are publicly available for download from the HapMap website (HapMap r23 build, http://www. hapmap.org). A threshold of 0.95 confidence level was set for a hard genotype call to be included in association testing. Most likely genotypes for imputed SNPs were then used in association analyses.
Statistical analysis
For statistical analysis, the PACS motor answers "no motor problems" and "possible motor problems" were combined into an " unaffected " category creating a binary outcome variable. We chose this rather strict way of analysis because standard deviations of motor scores were overlapping for the groups "no motor problems" and "possible motor problems" whilst the definitely affected category formed a truly different group (not shown). An ANOVA was performed with the binary PACS trait as independent and DCD-Q total scores as dependent variables to validate the motor question in a sample of 313 Dutch IMAGE participants for whom scores from PACS and DCD-Q were available. Of these, 296 also had complete data for covariates required for the genetic analysis. Association analysis of 890 ADHD probands with motor data was conducted using the logistic procedure implemented in PLINK with the motor variable from PACS as a binary outcome. The analysis was adjusted for age, gender, Conners' hyperactive/ impulsive score, Conners' inattentive score and the country in which the motor variable had been measured.
SNPs showing association P values < 10.00E-05 in the GWAS were tested for their association with the 4 subscales (fine and gross motor scores, general coordination and control during movement) of the DCD-Q. This association analysis was conducted in 296 Dutch ADHD probands using the linear procedure implemented in PLINK. Each DCD-Q variable was a continuous outcome and the models were adjusted for age, gender, Conners' hyperactive/impulsive score and Conners' inattentive score. In order to control for multiple testing, an extra permutation step was added to the linear test by applying the max(T) permutation approach implemented in PLINK. A total of 10,000 permutations were done for the subset of SNPs passing the P value threshold to determine empirical (EMP) P values for association.
Bioinformatics analysis
To detect significantly enriched gene functional groups in 97 genes from the GWAS containing at least one SNP showing association with the PACS motor variable at P < 10.00E-04, we performed functional analyses using Ingenuity Pathway Analysis (http://www.ingenuity .com). In the presentation of the results of these analyses, only gene categories with significant enrichment (i.e. false discovery rate corrected P < 0.05) and containing more than one gene were taken into account. The Ingenuity software package uses information from the published literature as well as many other sources, including gene expression and GO (gene ontology) terms data-bases, to assign genes to different groups and categories of functionally related genes. "Ingenuity genes" are assigned to one or more of three groups of gene functional categories, i.e. "diseases and disorders", "canonical pathways" and "physiological systems development and function". Each main category can be further divided into many subcategories (http://www. ingenuity.com).
In this study, we specifically looked at the five top-ranked "diseases and disorders" gene functional categories and subsequently at the five top-ranked subcategories within the "neurological disease" gene functional category. In addition, we looked at the top five "canonical pathways" and "physiological systems development and function" gene functional categories.
The NCBI databases (http://www. ncbi.nlm.nih.gov/sites/entrez/), the UCSC Genome Browser (http://genome.ucsc .edu), the HapMap project website (http://www.hapmap.org) and the website of the Sullivan Lab Evidence Project (http://slep.unc.edu) were used to retrieve information on gene function and prior association of the genes of interest with psychiatric disorders.
Results
A sample of 890 children with ADHD combined subtype had complete data. The mean age of the sample was 10.8 years (SD 2.8, age range 5 -17 years) and 85.3% was male (see Table I ). Of these, 199 children (22.4%) were reported by their parents to have definite motor problems, and 225 (25.3%) were noted with possible motor problems. Scores for the DCD-Q were available for 313 Dutch IMAGE individuals (Table I) . Groups based on PACS motor scores showed a significant difference in DCD-Q motor scores, both in total score (F = 36.89, P < 0.001) and subscale-scores (motor control in motion F = 16.45, P < 0.001; fine motor control/ handwriting F = 13.93, P < 0.001; gross motor control/planning F = 14.27, P < 0.001; general coordination F = 8.40, P = 0.004). Of those children showing definite motor problems in PACS (n = 92), 66 children (72%) also scored clinically on the DCD-Q total score (in the lowest 15th percentile of the normal population) (see Table 3 . Top single SNPs with P < 1.00E-04 from the GWAS for motor coordination problems in children with ADHD and DCD-Q results. The 24 SNPs showing a significant P-value for one of the DCD-Q results are indicated in bold. Table 4 . Top 5 'diseases and disorders' gene functional categories that are significantly enriched in the top 97 ADHD candidate genes from the GWAS for motor coordination problems in children with ADHD (see Supplementary Table 1) using Ingenuity pathway analysis. The 6 genes containing at least one SNP that yielded a P-value < 1.00E-04 (see Table 3 ) are indicated in bold. Table II ). The Spearman correlation between the scores on the motor coordination item of the PACS and the DCD-Q total score was -0.340 (P < 0.001).
A total of 580 SNPs showed association with PACS motor score at P values < 0.00E-04. The most significant associ-ation was observed for an intronic SNP in SLC7A2 (P value = 1.90E-06), 58 additional SNPs showed association P values < 10.00E-05 (Table III) . Of the 580 PACS-associated SNPs, 174 were located in 97 genes (Supplementary Table 1 ). Bioinformatics analysis using the Ingenuity program revealed that 45 of the 97 genes from the GWAS fell into the "neurological disease" gene category (P = 6.57E-06; Table IV) . These 45 genes were most significantly enriched in 5 subcategories of the "neurological disease" category: "neurodegenerative disorder" (22/97 genes; P = 6.57E-06), "progressive motor neuropathy" (23/97 genes; P = 2.10E-05), "amyotrophic lateral sclerosis" (15/97 genes; P = 5.42E-05) and two psychiatric disorders, "bipolar affective disorder" (19/97 genes; P = 7.40E-04) and "schizophrenia" (10/97 genes; P =1.01E-02) ( Table V) .
Other gene functional subcategories found significantly enriched in the 97 top candidate genes were "synaptic long term depression" (6/97 genes; P = 1.54E-02) and "nervous system development and function" (6/97 genes; P = 4.00E-02) (Table VI) .
Further characterization of the 59 SNPs showing P values = 10.00E-05 for association with the PACS motor score using a more elaborate measure of motor coordination, the DCD-Q, revealed 15 SNPs associated with different subscales with P values < 0.05 (Table III) . Permutation testing showed that two SNPs had significant empirical P values: rs11002745 for the gross motor scale (EMP P = 0.045) and rs2839083 for the fine motor scale (EMP P = 0.014). While most DCD-Q subscale associated SNPs influenced only one of the subscales, one SNP near the COL6A1 gene influenced control during movement and fine motor control (Table III) .
Of the 59 SNPs (Table III) , 17 were located within exonic, intronic or untranslated regions of nine different genes (see Supplementary Table 1 for information regarding gene function and published association with psychiatric disorders). A comprehensive search of the literature and databases indicated that eight of the nine encoded proteins function in a signalling network that operates in functional processes linked to neurite outgrowth, as recently also implicated in ADHD aetiology (Poelmans et al. 2011 ).
Interestingly, the same eight proteins are expressed in skeletal muscle, where they play important roles in basic muscle function (see Figure 1 and Supplementary File 1).
Discussion:
This report describes the first GWAS of motor coordination problems. Although none of the associations reached genomewide significance, i.e. a P value ≤ 7.20E-08 (Dudbridge and Gusnanto 2008) , the findings are intriguing and can give input to further hypothesis-driven follow-up studies.
The finding that eight of the nine proteins encoded by the top-ranked findings from our GWAS (with P values < 10.00E-05) function in a signalling network operating in neurite outgrowth is in line with another recent study of our group finding that 45 of the 85 top-ranked ADHD candidate genes from the five reported GWAS for ADHD are involved in neurite outgrowth (Poelmans et al. 2011) . The finding that the same eight genes/proteins are also involved in muscle function is in line with the view that motor coordination problems should not be viewed merely as a neuronal problem. They are related to the whole range of functional processes located in the cerebrum, cerebellum, motor neurons, neuromuscular junctions, muscle sensors and muscle cells. Motor skills are also the result of many different processes such as perceptual, feedback and learning processes, motor preparation Forty-five of the 97 genes identified by the GWAS (P < 10.00E-04) fell into the "neurological disease" functional gene category. Among the most significantly enriched subcategories were "progressive motor neuropathy" and "amyotrophic lateral sclerosis". Indeed, a relationship between ADHD and amyotrophic lateral sclerosis (ALS), an adult onset, polygenic disease of motor neuron degeneration Many patients developing ALS seem to have fulfilled clinical characteristics of ADHD earlier in their lives. At the neurobiological level, there is evidence for hyperactivity of the glutamatergic system and a dopaminergic hypoactivity in both ADHD and ALS (Lule et al. 2008) . Therefore, our finding provides further input to the hypothesis that ADHD may be a risk factor for the development of ALS. However, whether children with ADHD and motor coordination problems might be at a particularly high risk for developing ALS in later life needs to be explored in further studies.
The Ingenuity analysis further showed that the categories "synaptic long term depression" and "nervous system development and function" were significantly enriched in the 97 top-ranked genes. Long-term depression of neurotransmission leads to physical changes in neuronal circuits (Johnston 2009 ) and this neuronal plasticity allows reorganization of neuronal networks and learning. Given that motor learning disturbances such as difficulties in mastering new motor skills like swimming and riding a bicycle are a hallmark of motor coordination problems in children (Sugden 2007), our results are particularly interesting.
Apart from the enrichment of motor neuropathy and ALS genes in the topranked findings from the GWAS, more evidence of genes involved in motor dysfunction is present in our data: COL6A1 codes for a collagen found in most connective tissues and important in organizing extracellular matrix components. Mutations in this gene are known to cause motor problems in Bethlem myopathy and Ullrich scleroatonic muscular dystrophy (Lampe and Bushby 2005; Baker et al. 2007; Nadeau et al. 2009 ). Several patients with autosomal recessive myosclerosis also have mutations in this gene (Merlini et al. 2008) . The MAP2K5 gene, a member of the mitogen-activated protein kinase family, has been consistently associated with restless legs syndrome (RLS) -a neurological disorder characterized by uncomfortable and unpleasant sensations in the legs that occur at rest and induce an irresistible desire to move the legs -in GWAS (Winkelmann 2008; Kemlink et al. 2009; Trenkwalder et al. 2009) . A large population-based study has reported a prevalence of RLS of 2% in children and adolescents without ADHD (Picchietti and Picchietti 2008), whereas up to 44% of children with ADHD have symptoms of RLS (Cortese et al. 2005) . Several authors have already suggested that RLS and ADHD The association analysis of the candidate genes with the DCD-Q subscales provided insight into the sources of motor impairment at an additional level, in that it allowed us to characterize the movement "domain" that was influenced by the genetic variants identified. For 15 out of 59 tested SNPs, we found DCD-Q associations with P values < 0.05. The intergenic SNP rs11002745, located on chromosome 10, and SNP rs2839083, located 18.7 kb downstream of the COL6A1 gene on chromosome 21, survived multiple testing correction. The former SNP showed association with gross motor problems, the latter SNP was associated with fine motor problems and control during movement. As children with motor coordination problems show a heterogeneous phenotype, with some of them being mainly disturbed in fine and others in gross motor performance (Polatajko and Cantin 2005; Green et al. 2008) , it is not surprising that we find these different associations.
This is the first GWAS of motor coordination problems and should be viewed as only a first step in identifying genetic factors contributing to these problems. Our study was underpowered, even though we collected a large sample of children with motor coordination problems in which we tried to maximize genetic homogeneity of the motor coordination problems by just focusing on children with ADHD. Another potential limitation of our study is the sparseness of the motor assessment in the international IMAGE sample, with only one question pertaining to motor problems in the PACS. Recognizing this, we chose a conservative approach in pooling the unaffected and possibly affected individuals together as non-affected, which has probably reduced the power of our study. Still, the affected group might show different types of motor problems, as is also suggested by the fact that 28% of people scoring positive for motor problems on PACS scored negative on the more extensive DCD-Q.
The overall correlation of the PACS item with the total DCD-Q score was thus modest, which supports the validity of the PACS item but also indicates that this item and the DCD-Q measure somewhat different movement problems. In addition, it would have been preferable to use objective motor tests in our study. However, these tests are time-consuming, expensive and less compatible with testing large samples of children, as was done in our study. Nevertheless, the substantial evidence of the involvement of the genes from the top-ranks of this GWAS in other movement disorders strongly validates our approach.
Replication studies in independent samples are necessary to confirm or refute the presented results. In addition, replication of these findings is needed in samples of children with DCD who were not primarily selected as suffering from ADHD. However, despite extensive efforts from our side to find such samples, at the current time, they do not seem to be available in the international research community.
Taken together, our findings raise the intriguing possibility that motor coordination problems are associated with genes expressed in both nerve tissue and skeletal muscle.
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Supplementary file 1
Signalling through the proposed network can be initiated at the skeletal muscle cell membrane (Fig.1a) by ADCY2 (adenylate cyclase 2), a cell membrane protein (Uniprot Consortium 2010) that is also found in the cytoplasm and that is expressed in skeletal muscle and brain (Sunahara and Taussig 2002) . ADCY2 is activated by the binding of hormones such as dopamine and prostaglandin to cell surface receptors which interact with intracellular G proteins (Sunahara and Taussig 2002) (not shown in Fig. 1 ).
ADCY2 produces cAMP (Jones and Kuhar 2006) , which subsequently activates PKA (protein kinase A) (Fig.1b) and can be negatively regulated by the inhibitory G protein subunit GNAI2 (Grishina and Berlot 1997) . In skeletal muscle, PKA activates the transcription factor function of catenin beta (CTNNB) (Hino et al. 2005) and inhibits AMPK (Djouder et al. 2010) and MAPK7 (Pearson et al. 2006 ) (see below) (Fig.1b) . PKA is targeted to the proteins it activates or inhibits by the PKA anchoring protein AKAP6 (Fig.1c) , expressed in the nucleus membrane of skeletal muscle and brain cells, and encoded by AKAP6 (Dodge-Kafka and Kapiloff 2006; Uniprot Consortium 2010), one of the 97 candidate genes containing at least one GWAS SNP with P < 10.00E-04 (see Supplementary Table 1) . CTNNB can also be bound and trans-activated by TCF7L1, another transcription factor (Uniprot Consortium 2010) (Fig.1c) . In the nucleus of skeletal muscle cells, CTNNB functions as a transcription factor (Fig.1c) that promotes the self-renewal of these cells (Perez-Ruiz et al. 2008) . The kinase MAPK7 (also known as: ERK5), which is highly expressed in brain and skeletal muscle (Fig.1b) , is activated by MAP2K5 (Uniprot Consortium 2010). MAP2K5 is itself a cytoplasmic kinase (Fig.1b) that is expressed in many tissues, including skeletal muscle -where it is particularly abundant -and brain (Uniprot Consortium 2010) , and that is activated in a signalling cascade downstream of IGF-2, a growth factor that initiates important signals in myogenesis (Carter et al. 2009 ). Upon activation, MAPK7 translocates to the nucleus where it activates/phosphorylates transcription factors of the MEF2 (myocyte enhancer factor 2) protein family (Uniprot Consortium 2010) (Fig.1c) .
The MEF2 proteins, in turn, up-regulate the transcription and expression of numerous muscle specific genes by specifi cally binding to the MEF element/domain in these genes (Uniprot Consortium 2010) (Fig.1c) . In this way, the MEF2 proteins are e.g. involved in skeletal muscle glucose uptake by up-regulating the expression of the GLUT4 glucose transporter (Zorzano et al. 2005; Lira et al. 2007; Wright 2007 ).
Another ubiquitously expressed transcription factor in the network is CHD6 (Uniprot Consortium 2010). CHD6 activates NRF2 (Nioi et al. 2005) , another transcription factor that is also widely expressed, with highest expression in (adult and foetal) muscle (Uniprot Consortium 2010) (Fig.1c) . NRF2 upregulates the expression of GNAI2, the negative regulator of ADCY2 (see above), by trans-activating the GNAI2 promoter (Arinze and Kawai 2005) .
Also contributing to the network is SLC7A2, a membrane transporter (Fig.1a) for the cationic amino acids (arginine, lysine and ornithine) (Uniprot Consortium 2010) that is (highly) expressed in skeletal muscle (Uniprot Consortium 2010) and brain (Colton et al. 2006 ). One of the major products of intracellular arginine is nitric oxide (NO) (Fig.1b and Fig.1e) , which is synthesized by the NOS1 enzyme in skeletal muscle (Grozdanovic 2001; Harris et al. 2008) (Fig.1b) . NO stimulates the expression of the GLUT4 glucose transporter in skeletal muscle through AMPK and MEF2 proteins (Zorzano et al. 2005; Lira et al. 2007; Wright 2007) (Fig.1b  and Fig.1c) . FLCN encodes the cytoplasmic folliculin (Fig.1b) , which is expressed in many tissues including skeletal muscle and brain (Uniprot Consortium 2010) and is directly activated by the AMPK kinase (Wang et al. 2010) . FLCN is also directly involved in mTOR kinase signalling pathways (not shown in Fig.1 ), which are important for skeletal muscle protein synthesis and hence skeletal muscle mass (Fujita et al. 2007; Uniprot Consortium 2010) .
In addition to the network involved in muscle maintenance and function as described above, two additional genes from the top findings play a role in muscle function: PLD6 is a protein that is located in the (outer) membrane of mitochondria (Fig.1b and Fig.1d ).
It induces mitochondrial fusion through the formation of a dimer with a PLD6 protein on the outer membrane of a nearby mitochondrion (Choi et al. 2006) .
WDFY3 is highly expressed in skeletal muscle and brain and encodes WD repeat and FYVE domain containing protein 3, a membrane protein that targets cytosolic protein aggregates for autophagic degradation (Simonsen et al. 2004 ). Both mitochondrial fusion (Zorzano 2009; Ding et al. 2010; Zorzano et al. 2010 ) and autophagic degradation (Raben et al. 2009; Schoser 2009 ) play important roles in (ab) normal skeletal muscle function. Importantly, most of the genes and signalling cascades described above, and most notably the GNAI2-ADCY2-PKA-CTNNB (Grishina and Berlot 1997; Sunahara and Taussig 2002; Hino et al. 2005; Votin et al. 2005; Jones and Kuhar 2006) and MAP2K5-MAPK7-MEF2 (Li et al. 2001; Liu et al. 2003; Lam and Chawla 2007) cascades and NRF2 (Kosaka et al. 2010 ) also function in neurite outgrowth (Poelmans et al. 2011 
